Difference Between GHRH and GHRP Peptides
GH peptides fall into two distinct classes — GHRH analogues and GHRPs — that work on completely different receptors and play different roles in GH release. Understanding the distinction explains why combining one from each class produces dramatically more GH than either alone, and helps clarify which specific compounds to choose for different research goals.
GHRH Analogues = "Get Ready"
Mimic the hypothalamus signal. Activate the GHRH receptor on pituitary cells. Prime them to produce and release GH. The pituitary cells are loaded and ready — but haven't fired yet.
Analogy: Loading a spring
GHRPs = "Release Now"
Mimic ghrelin — the hunger hormone. Activate the GHS-R1a (ghrelin receptor) on pituitary cells. This is the actual trigger signal that releases the GH burst that was primed by GHRH.
Analogy: Releasing the spring
When both signals arrive simultaneously — one from a GHRH analogue and one from a GHRP — a larger pool of primed cells fires at once. The result is a GH pulse significantly larger than either signal could produce alone. This is the mechanistic foundation of the CJC-1295 + Ipamorelin stack.
GHRH Analogues — Full List
| Peptide | Half-life | Dose | Frequency | Notes |
|---|---|---|---|---|
| CJC-1295 (No DAC) | ~30 minutes | 100–200 mcg | 2–3x daily | Most popular GHRH analogue; preferred for stacking |
| CJC-1295 (With DAC) | ~8 days | 1–2 mg | 1–2x weekly | Long-acting convenience; sustained GHRH signal |
| Sermorelin | ~10–20 minutes | 200–300 mcg | Once daily | Clinically used; available by prescription; natural GHRH analogue |
| Tesamorelin | ~26 minutes | 1–2 mg | Once daily | FDA-approved for HIV lipodystrophy; potent GHRH analogue with clinical data |
GHRPs (Ghrelin Mimetics) — Full List
| Peptide | Selectivity | Dose | Notes |
|---|---|---|---|
| Ipamorelin | GH only (minimal cortisol/prolactin) | 100–300 mcg | Cleanest GHRP profile; preferred for most research stacks |
| GHRP-6 | GH + significant hunger + some cortisol | 100–300 mcg | Oldest GHRP; strong GH pulse but high hunger side effect |
| GHRP-2 | GH + elevated cortisol + some prolactin | 100–300 mcg | More potent than GHRP-6; higher cortisol/prolactin concerns |
| Hexarelin | Very strong GH + strong cortisol + desensitisation risk | 100–200 mcg | Most potent GHRP; develops tolerance relatively quickly; less commonly used |
Maximum GH output with minimum side effects
CJC-1295 No DAC + Ipamorelin stack. Best evidence, cleanest side effect profile, synergistic at the receptor level.
Convenient low-frequency dosing
CJC-1295 With DAC (1–2x weekly) + Ipamorelin daily. With DAC handles the weekly GHRH burden; Ipamorelin triggers daily pulses.
Clinical / prescribed pathway
Sermorelin via licensed practitioner. The only GHRH analogue readily available by prescription in many jurisdictions.
Fat loss specific (with clinical data)
Tesamorelin (FDA-approved for visceral fat reduction). The only GH secretagogue with approved human fat loss data.
Maximum raw GH output (research)
CJC-1295 No DAC + GHRP-2 or Hexarelin stack. Higher GH but at the cost of cortisol elevation and desensitisation risk.
Research use only. All compounds described (except Sermorelin and Tesamorelin via prescription) are research-only and not FDA-approved for general human use. Educational purposes only.
GH Peptides Guides
Other Articles
Calculator
Calculate exact reconstitution volumes and insulin unit doses for any peptide protocol.
Open Calculator →
